Ra. Kiivet et al., PATTERNS OF DRUG-TREATMENT OF SCHIZOPHRENIC-PATIENTS IN ESTONIA, SPAIN AND SWEDEN, British journal of clinical pharmacology, 40(5), 1995, pp. 467-476
1 Patterns of drug treatment and the use of polypharmacy in schizophre
nic in-patients were compared and evaluated in the University Teaching
Hospitals of Psychiatry in Badajoz, Spain, Huddinge, Sweden, and Tart
u, Estonia. 2 The medical records of up to 100 consecutively admitted
patients were retrospectively reviewed using a standardized data form.
3 The male patients were significantly younger than females in all st
udy locations, but there were no age differences between the locations
. The length of stay was equal for the two series in the same hospital
, but considerably longer in Tartu than in Badajoz and Huddinge. 4 The
neuroleptic drugs used most commonly in Badajoz and Tartu were simila
r in prescription frequency and in the doses prescribed, but different
from those used in Huddinge. Haloperidol was the most frequently pres
cribed neuroleptic in Badajoz and Tartu, accounting for one third of a
ll neuroleptic prescriptions. In Huddinge the choice of neuroleptics w
as more evenly spread over several compounds. Intramuscular injections
other than depot preparations were commonly used in Tartu and Badajoz
, but not in Huddinge. 5 At least two neuroleptics were prescribed sim
ultaneously on 73% of treatment days in Badajoz and 46% in both Huddin
ge and Tartu. The average cumulative daily doses of concomitant multip
le neuroleptic treatment, expressed in chlorpromazine equivalents, wer
e lower in Huddinge than in the other study locations and higher for m
ale patients in Badajoz and Tartu. 6 Anticholinergics were used togeth
er with neuroleptics in 42% of treatment days in Badajoz and 30% in Hu
ddinge as compared with 75% in Tartu. The use of anticholinergics incr
eased in parallel to the increase in the number and the cumulative dos
e of concomitant neuroleptics in all study locations. 7 About 15% of p
atients in Badajoz and Tartu, but only 1% in Huddinge, received concom
itant treatment with antidepressant drugs. The simultaneous use of ant
idepressants and benzodiazepines was inversely related to the number a
nd the cumulative dose of neuroleptics in Badajoz and Tartu. In contra
st, the cumulative dose and number of neuroleptics were greater, when
additional benzodiazepines were prescribed in Huddinge. 8 The study in
schizophrenic in-patients revealed that polypharmacy with concomitant
multiple neuroleptics, additional anticholinergics and other psychotr
opics is an international phenomenon.